3 terminated. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 3 |
| Phase 3 | 1 | Terminated 1 |
Follow Respiratory Failure: new trials by email Literature Review of Respiratory Failure trials Research Report on Respiratory Failure
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Furosemide as Supportive Therapy for COVID-19 Respiratory Failure Nebulized Furosemide, Nebulized Saline - Covid19, Respiratory Failure | Phase 2 / Phase 3 | Terminated | Dr. John Muscedere | 40 | 2021-04-16 | 2023-12-11 |
| Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS). Pemziviptadil (PB1046), Low Dose (10 mg) Control - Acute Respiratory Distress Syndrome, Coronavirus | Phase 2 | Terminated | PhaseBio Pharmaceuticals Inc. | 54 | 2020-07-15 | 2020-12-11 |
| Study of Sildenafil to Treat Newborns With Persistent Pulmonary Hypertension Intravenous Sildenafil, Placebo - Persistent Pulmonary Hypertension, Respiratory Failure | Phase 2 | Terminated | University of Colorado, Denver | 3 | 2011-07-01 | 2019-02-01 |
Respiratory Insufficiency (3) · COVID-19 (2) · Cardiovascular Diseases (1) · Coronavirus Infections (1) · Cytokine Release Syndrome (1) · Dyspnea (1) · Heart Failure (1) · Hypertension, Pulmonary (1) · Myocardial Infarction (1) · Pneumonia (1) · Pulmonary Edema (1) · Respiratory Distress Syndrome (1)
Lung Diseases (3) · Respiration Disorders (3) · Respiratory Tract Diseases (3) · Coronaviridae Infections (2) · Infections (2) · Nidovirales Infections (2) · Pneumonia, Viral (2) · RNA Virus Infections (2) · Respiratory Tract Infections (2) · Vascular Diseases (2) · Virus Diseases (2) · Cardiovascular Diseases (1) · Coronavirus Infections (1) · Heart Diseases (1) · Hypertension (1)
Sildenafil Citrate (1) · VIP-ELP fusion molecule PB1046 (1)
Dr. John Muscedere (1) · PhaseBio Pharmaceuticals Inc. (1) · University of Colorado, Denver (1)
United States (2) · Canada (1)
John Kinsella, MD (1) · John Muscedere, MD (1)
U01HL102235 (1)